{"id":10572,"date":"2026-03-12T09:50:06","date_gmt":"2026-03-12T13:50:06","guid":{"rendered":"https:\/\/www.rigicon.com\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-de\/"},"modified":"2026-03-12T09:50:06","modified_gmt":"2026-03-12T13:50:06","slug":"first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-de","status":"publish","type":"clinical-evidence","link":"https:\/\/www.rigicon.com\/de\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-de\/","title":{"rendered":"Erste Sicherheitsergebnisse des k\u00fcnstlichen Harnschlie\u00dfmuskels ContiReflex\u00ae zur Behandlung m\u00e4nnlicher Inkontinenz"},"excerpt":{"rendered":"","protected":false},"featured_media":0,"template":"","tags":[],"ce_category":[238],"ce_product":[268],"class_list":["post-10572","clinical-evidence","type-clinical-evidence","status-publish","hentry","ce_category-poster-abstracts-de","ce_product-contireflex-de"],"acf":{"ce_paper_title":"","ce_year":2024,"ce_journal":"The Journal of Urology","ce_doi":"https:\/\/www.auajournals.org\/doi\/10.1097\/01.JU.0001009488.55564.85.16","ce_summary":"Eine multizentrische Analyse von 50 Patienten zeigte, dass der ContiReflex\u00ae AUS sicher und wirksam ist, ohne Infektionen, ohne Erosionen und mit einem 18-Monats-Ger\u00e4te\u00fcberleben von 98%.","ce_authors":"Steven K. Wilson, Eric Chung, Brian Langford, Rowland Rees, Dominic Lee, Ricardo Schlessinger, George Koufogiannis, Daniel Moon, Koenraad Van Renterghem","ce_objective":"<p class=\"ai-optimize-6\">Bewertung des fr\u00fchen Sicherheitsprofils und der chirurgischen Ergebnisse des k\u00fcnstlichen Harnschlie\u00dfmuskels Rigicon ContiReflex<sup>\u00ae<\/sup> bei der Behandlung m\u00e4nnlicher Belastungsinkontinenz.<\/p>","ce_key_findings":"<p class=\"ai-optimize-7\">Unter 50 Patienten traten keine Infektionen oder Erosionen auf. Eine Revision (2%) war erforderlich. Eine Kaplan-Meier-Analyse zeigte ein Ger\u00e4te\u00fcberleben von 98% nach 18 Monaten.<\/p>","ce_conclusion":"<p class=\"ai-optimize-8\">Der k\u00fcnstliche Harnschlie\u00dfmuskel Rigicon ContiReflex<sup>\u00ae<\/sup> zeigt ein g\u00fcnstiges fr\u00fches Sicherheitsprofil und ist vergleichbar mit bestehenden Schlie\u00dfmuskelger\u00e4ten bei der Behandlung m\u00e4nnlicher Inkontinenz.<\/p>","ce_clinical_relevance":"<p class=\"ai-optimize-9\">Der ContiReflex<sup>\u00ae<\/sup> AUS bietet eine vielversprechende Option f\u00fcr die Behandlung m\u00e4nnlicher Inkontinenz mit hervorragenden fr\u00fchen Sicherheitsergebnissen, die eine breitere klinische Anwendung unterst\u00fctzen.<\/p>","ce_pdf":null,"ce_logos":null,"ce_featured":true,"ce_keywords":"ContiReflex\u00ae, k\u00fcnstlicher Harnschlie\u00dfmuskel, m\u00e4nnliche Inkontinenz, AUS, Rigicon, Ger\u00e4tesicherheit, chirurgische Ergebnisse, Urologie"},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Sicherheitsergebnisse ContiReflex\u00ae AUS - Rigicon\u00ae<\/title>\n<meta name=\"description\" content=\"Eine multizentrische Analyse von 50 Patienten zeigte, dass der ContiReflex\u00ae AUS sicher und wirksam ist, ohne Infektionen, ohne...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rigicon.com\/de\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-de\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Erste Sicherheitsergebnisse des k\u00fcnstlichen Harnschlie\u00dfmuskels ContiReflex\u00ae zur Behandlung m\u00e4nnlicher Inkontinenz | Peer-Reviewed Research\" \/>\n<meta property=\"og:description\" content=\"Eine multizentrische Analyse von 50 Patienten zeigte, dass der ContiReflex\u00ae AUS sicher und wirksam ist, ohne Infektionen, ohne Erosionen und mit einem 18-Monats-Ger\u00e4te\u00fcberleben von 98%.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rigicon.com\/de\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-de\/\" \/>\n<meta property=\"og:site_name\" content=\"Rigicon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/rigiconurology\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/04\/header-d.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1440\" \/>\n\t<meta property=\"og:image:height\" content=\"718\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@rigiconurology\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/clinical-evidence\\\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-de\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/clinical-evidence\\\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-de\\\/\",\"name\":\"Sicherheitsergebnisse ContiReflex\u00ae AUS - Rigicon\u00ae\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/#website\"},\"datePublished\":\"2026-03-12T13:50:06+00:00\",\"description\":\"Eine multizentrische Analyse von 50 Patienten zeigte, dass der ContiReflex\u00ae AUS sicher und wirksam ist, ohne Infektionen, ohne...\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/clinical-evidence\\\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-de\\\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rigicon.com\\\/de\\\/clinical-evidence\\\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-de\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/clinical-evidence\\\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-de\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Klinische Evidenz\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/clinical-evidence\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Erste Sicherheitsergebnisse des k\u00fcnstlichen Harnschlie\u00dfmuskels ContiReflex\u00ae zur Behandlung m\u00e4nnlicher Inkontinenz\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/\",\"name\":\"Rigicon\",\"description\":\"Innovative Urological Solutions\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/#organization\"},\"alternateName\":\"Innovative Urological Solutions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de-DE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/#organization\",\"name\":\"Rigicon, Inc.\",\"alternateName\":\"Innovative Urological Solutions\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"width\":512,\"height\":512,\"caption\":\"Rigicon, Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/x.com\\\/rigiconurology\",\"https:\\\/\\\/www.instagram.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@Rigicon\\\/podcasts\",\"https:\\\/\\\/www.youtube.com\\\/Rigicon\",\"https:\\\/\\\/www.threads.net\\\/@rigiconurology\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/rigicon\\\/\"],\"description\":\"Rigicon is a global provider of innovative, diverse, and complete portfolio of prosthetic urology options.\",\"email\":\"operations@rigicon.com\",\"telephone\":\"+1 (888) 202-9790\",\"legalName\":\"Rigicon, Inc.\",\"vatID\":\"81-3545645\",\"taxID\":\"81-3545645\",\"duns\":\"045247683\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sicherheitsergebnisse ContiReflex\u00ae AUS - Rigicon\u00ae","description":"Eine multizentrische Analyse von 50 Patienten zeigte, dass der ContiReflex\u00ae AUS sicher und wirksam ist, ohne Infektionen, ohne...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rigicon.com\/de\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-de\/","og_locale":"de_DE","og_type":"article","og_title":"Erste Sicherheitsergebnisse des k\u00fcnstlichen Harnschlie\u00dfmuskels ContiReflex\u00ae zur Behandlung m\u00e4nnlicher Inkontinenz | Peer-Reviewed Research","og_description":"Eine multizentrische Analyse von 50 Patienten zeigte, dass der ContiReflex\u00ae AUS sicher und wirksam ist, ohne Infektionen, ohne Erosionen und mit einem 18-Monats-Ger\u00e4te\u00fcberleben von 98%.","og_url":"https:\/\/www.rigicon.com\/de\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-de\/","og_site_name":"Rigicon","article_publisher":"https:\/\/www.facebook.com\/rigiconurology\/","og_image":[{"width":1440,"height":718,"url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/04\/header-d.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@rigiconurology","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rigicon.com\/de\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-de\/","url":"https:\/\/www.rigicon.com\/de\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-de\/","name":"Sicherheitsergebnisse ContiReflex\u00ae AUS - Rigicon\u00ae","isPartOf":{"@id":"https:\/\/www.rigicon.com\/de\/#website"},"datePublished":"2026-03-12T13:50:06+00:00","description":"Eine multizentrische Analyse von 50 Patienten zeigte, dass der ContiReflex\u00ae AUS sicher und wirksam ist, ohne Infektionen, ohne...","breadcrumb":{"@id":"https:\/\/www.rigicon.com\/de\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-de\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rigicon.com\/de\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-de\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rigicon.com\/de\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-de\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.rigicon.com\/de\/"},{"@type":"ListItem","position":2,"name":"Klinische Evidenz","item":"https:\/\/www.rigicon.com\/de\/clinical-evidence\/"},{"@type":"ListItem","position":3,"name":"Erste Sicherheitsergebnisse des k\u00fcnstlichen Harnschlie\u00dfmuskels ContiReflex\u00ae zur Behandlung m\u00e4nnlicher Inkontinenz"}]},{"@type":"WebSite","@id":"https:\/\/www.rigicon.com\/de\/#website","url":"https:\/\/www.rigicon.com\/de\/","name":"Rigicon","description":"Innovative Urological Solutions","publisher":{"@id":"https:\/\/www.rigicon.com\/de\/#organization"},"alternateName":"Innovative Urological Solutions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rigicon.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de-DE"},{"@type":"Organization","@id":"https:\/\/www.rigicon.com\/de\/#organization","name":"Rigicon, Inc.","alternateName":"Innovative Urological Solutions","url":"https:\/\/www.rigicon.com\/de\/","logo":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.rigicon.com\/de\/#\/schema\/logo\/image\/","url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","contentUrl":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","width":512,"height":512,"caption":"Rigicon, Inc."},"image":{"@id":"https:\/\/www.rigicon.com\/de\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/rigiconurology\/","https:\/\/x.com\/rigiconurology","https:\/\/www.instagram.com\/rigiconurology\/","https:\/\/www.youtube.com\/@Rigicon\/podcasts","https:\/\/www.youtube.com\/Rigicon","https:\/\/www.threads.net\/@rigiconurology","https:\/\/www.linkedin.com\/company\/rigicon\/"],"description":"Rigicon is a global provider of innovative, diverse, and complete portfolio of prosthetic urology options.","email":"operations@rigicon.com","telephone":"+1 (888) 202-9790","legalName":"Rigicon, Inc.","vatID":"81-3545645","taxID":"81-3545645","duns":"045247683"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.rigicon.com\/de\/wp-json\/wp\/v2\/clinical-evidence\/10572","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rigicon.com\/de\/wp-json\/wp\/v2\/clinical-evidence"}],"about":[{"href":"https:\/\/www.rigicon.com\/de\/wp-json\/wp\/v2\/types\/clinical-evidence"}],"wp:attachment":[{"href":"https:\/\/www.rigicon.com\/de\/wp-json\/wp\/v2\/media?parent=10572"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rigicon.com\/de\/wp-json\/wp\/v2\/tags?post=10572"},{"taxonomy":"ce_category","embeddable":true,"href":"https:\/\/www.rigicon.com\/de\/wp-json\/wp\/v2\/ce_category?post=10572"},{"taxonomy":"ce_product","embeddable":true,"href":"https:\/\/www.rigicon.com\/de\/wp-json\/wp\/v2\/ce_product?post=10572"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}